2 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Bernstein, Jonathan A., M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema ecallantide - Kallikrein inhibitor that blocks the production of bradykinin - Angioedema | Phase 2 | Unknown | Bernstein, Jonathan A., M.D. | 50 | 2010-05-01 | 2012-03-09 |
| Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) montelukast, placebo - Rhinitis | Phase 4 | Unknown | Bernstein, Jonathan A., M.D. | 6 | 2006-11-01 | 2009-01-16 |
Angioedema (1) · Rhinitis (1)
montelukast (1)
United States (2)
Jonathan A Bernstein, MD (1) · Jonathan A. Bernstein, M.D. (1) · Joseph Moellman, MD (1)